具有pH值敏感的富甲氨酸载入的聚合物纳米粒子作为乳腺癌治疗的新治疗策略
Katarzyna Malarz1, Wioleta Borzęcka2, Patryk Ziola3
1Department of Systems Biology and Engineering, Silesian University of Technology, Akademicka 2A, 44-100 Gliwice, Poland; A. Chełkowski Institute of Physics, University of Silesia in Katowice, 75 Pułku Piechoty 1a, 41-500 Chorzów, Poland.
Bioorganic chemistry
|January 11, 2025
概括
携带氨酸的新型聚合物纳米颗粒显示为乳腺癌治疗的前景. 这些pH敏感载体可以改善药物传递到瘤细胞,提高疗效并降低毒性.
科学领域:
- 材料科学 材料科学 材料科学
- 在瘤学瘤学.
- 生物化学 生物化学
背景情况:
- 聚氨酸 (Pc) 被研究为光动力学疗法 (PDT) 的光敏化剂.
- 开发有针对性的药物输送系统对于有效的乳腺癌治疗至关重要.
- 瘤微环境通常是酸性的,对药物透具有挑战性.
研究的目的:
- 开发新的pH敏感的聚合物纳米粒子 (NP) 载体,用于氨酸 (Pc) 光敏剂.
- 评估这些PC载荷NP在乳腺癌治疗中的疗效和作用机制.
- 评估开发的药物输送系统的安全性和选择性.
主要方法:
- 聚合和表征pH敏感的聚合物NP封装氨酸 (Pc4-NP和TT1-NP).
- 对SK-BR-3乳腺癌细胞和健康纤维细胞的光细胞毒性研究.
- 评估细胞吸收,反应性氧物种 (ROS) 生成,细胞局部化,以及关键信号蛋白的西斑分析 (Akt,HER-2通路,GLUT-1,HO-1,p42/44,BID).
主要成果:
- Pc载荷的NP显示出高的抗增殖活性和针对SK-BR-3细胞的特异性.
- 聚合物NP封装显著增强了Pc透到酸性瘤细胞环境中.
- 在没有照射的情况下,PC-NP对癌细胞具有很高的选择性,对纤维细胞没有观察到毒性.
- 作用机制涉及ROS生成,破坏细胞平衡,诱导氧化应激和细胞死亡.
- 化合物抑制了Akt蛋白表达和酸化,这对于HER-2过度表达的乳腺癌至关重要.
结论:
- 对pH敏感的聚合物酸纳米颗粒是乳腺癌光动力疗法的有效和选择性药物递送系统.
- 增强的瘤细胞透和向的ROS生成有助于它们的治疗疗效.
- 抑制Akt信号通路代表了治疗特定乳腺癌亚型的额外治疗优势.
相关概念视频
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...


